Malcisbo Company
Malcisbo is a company that creates carbohydrate-based vaccines for human and animal health. Their focus is on parasitic diseases, human food safety, and zoonotic diseases. They have a proprietary target discovery platform that identifies carbohydrates as vaccine targets and uses glycoengineering technologies to develop efficient glycoconjugate vaccines. Malcisbo aims to develop affordable vaccines to protect people in underdeveloped areas against parasitic worm infections. They specialize in glycoengineering technologies to create low-cost glycoconjugate vaccines for bacterial diseases targeting animal health, human food safety, and zoonotic diseases.
Industry:
Medical Technology
Estimated Revenue:
Less than $1M
Headquarters:
Zurich